DE60136002D1 - Parenteral verabreichbare mikropartikel-zubereitung mit kontrollierter freisetzung - Google Patents

Parenteral verabreichbare mikropartikel-zubereitung mit kontrollierter freisetzung

Info

Publication number
DE60136002D1
DE60136002D1 DE60136002T DE60136002T DE60136002D1 DE 60136002 D1 DE60136002 D1 DE 60136002D1 DE 60136002 T DE60136002 T DE 60136002T DE 60136002 T DE60136002 T DE 60136002T DE 60136002 D1 DE60136002 D1 DE 60136002D1
Authority
DE
Germany
Prior art keywords
parenterally
administrative
controlled release
microparticle preparation
curve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60136002T
Other languages
English (en)
Inventor
Mats Reslow
Soeren Bjoern
Joern Drustrup
Nils Ove Gustafsson
Monica Joensson
Timo Laakso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacira Pharmaceuticals Inc
Original Assignee
Pacira Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003614A external-priority patent/SE517610C2/sv
Application filed by Pacira Pharmaceuticals Inc filed Critical Pacira Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60136002D1 publication Critical patent/DE60136002D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
DE60136002T 2000-10-06 2001-10-05 Parenteral verabreichbare mikropartikel-zubereitung mit kontrollierter freisetzung Expired - Fee Related DE60136002D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003614A SE517610C2 (sv) 2000-10-06 2000-10-06 Mikropartikelberedning
US26049501P 2001-01-08 2001-01-08
PCT/SE2001/002165 WO2002028375A1 (en) 2000-10-06 2001-10-05 A controlled-release, parenterally administrable microparticle preparation

Publications (1)

Publication Number Publication Date
DE60136002D1 true DE60136002D1 (de) 2008-11-13

Family

ID=26655254

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136002T Expired - Fee Related DE60136002D1 (de) 2000-10-06 2001-10-05 Parenteral verabreichbare mikropartikel-zubereitung mit kontrollierter freisetzung

Country Status (8)

Country Link
US (1) US7033609B2 (de)
EP (1) EP1328258B1 (de)
JP (1) JP2004510730A (de)
AT (1) ATE409465T1 (de)
AU (1) AU2001294459A1 (de)
CA (1) CA2424896A1 (de)
DE (1) DE60136002D1 (de)
WO (1) WO2002028375A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
EP1726299A3 (de) * 2005-05-27 2007-04-18 StratoSphere Pharma AB Kerne und Mikrokapsel zur parenteralen Verabreichung sowie Verfahren zu deren Herstellung
US20080293637A1 (en) * 2007-05-23 2008-11-27 Allergan, Inc. Cross-linked collagen and uses thereof
JP2010528039A (ja) * 2007-05-23 2010-08-19 アラーガン、インコーポレイテッド 被覆されたヒアルロン酸粒子
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
MX2010005331A (es) 2007-11-16 2010-08-11 Vicept Therapeutics Inc Composiciones y metodos para tratamiento de purpura.
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8450475B2 (en) * 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2658609T3 (es) 2008-09-02 2018-03-12 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos, y usos de los mismos
CN101574638B (zh) * 2009-06-15 2012-04-18 中国农业大学 一种淀粉纳米微球及其制备方法
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20130052647A1 (en) * 2010-02-10 2013-02-28 Marianna Goldrick Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery
NZ602405A (en) * 2010-03-12 2014-12-24 Allergan Ind Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
WO2011119468A1 (en) 2010-03-22 2011-09-29 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
WO2012167079A2 (en) 2011-06-03 2012-12-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE744162A (fr) 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
US3881991A (en) 1969-01-24 1975-05-06 Hayashibara Co Process for producing amylose powders having a mean degree of polymerization between 20{14 30
DE2010115A1 (de) 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrogranulaten
US4389330A (en) 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4713249A (en) 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
EP0471036B2 (de) 1989-05-04 2004-06-23 Southern Research Institute Einkapselungsverfahren
DK168790D0 (de) 1990-07-13 1990-07-13 Novo Nordisk As
KR100259989B1 (ko) 1991-10-01 2000-08-01 모리다 가쓰라 서방성 마이크로캡슐 제제 및 그의 제조법
US5470582A (en) 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
WO1993021008A1 (en) 1992-04-20 1993-10-28 Redding Bruce K Jr Method and apparatus for the modification of starch and other polymers
PT674506E (pt) 1992-12-02 2001-01-31 Alkermes Inc Microsferas contendo hormona de crescimento com libertacao controlada
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
PT809110E (pt) 1993-03-09 2004-06-30 Baxter Int Microparticulas macromoleculares e metodos de producao
DE4434877A1 (de) 1994-09-29 1996-04-04 Fresenius Ag Verfahren zur Herstellung von Stärkeabbauprodukten
KR100201352B1 (ko) 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
US5959102A (en) 1997-06-30 1999-09-28 Rutgers University Starch purification by thermally tolerant broad pH range proteolytic enzymes
SE512663C2 (sv) 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
JPH11302156A (ja) 1998-04-16 1999-11-02 Tanabe Seiyaku Co Ltd ポリペプチドの微粒子化方法
SE517422C2 (sv) * 2000-10-06 2002-06-04 Bioglan Ab Farmaceutiskt acceptabel stärkelse

Also Published As

Publication number Publication date
JP2004510730A (ja) 2004-04-08
US20020102311A1 (en) 2002-08-01
WO2002028375A1 (en) 2002-04-11
US7033609B2 (en) 2006-04-25
CA2424896A1 (en) 2002-04-11
EP1328258A1 (de) 2003-07-23
AU2001294459A1 (en) 2002-04-15
ATE409465T1 (de) 2008-10-15
EP1328258B1 (de) 2008-10-01

Similar Documents

Publication Publication Date Title
DE60136002D1 (de) Parenteral verabreichbare mikropartikel-zubereitung mit kontrollierter freisetzung
MY118835A (en) Sustained release compositions and the process for their preparation
DE58909072D1 (en) Alloplastisches implantat.
DK0794790T3 (da) Lokaliseret afgivelse af faktorer, der øger overlevelsen af transplanterede celler
SG83819A1 (en) Copolymers having nitrile and alicyclic leaving groups and photoresist compositions comprising same
TW364841B (en) Toothbrush
DK1137400T3 (da) Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode
FR2814360B1 (fr) Injecteur d'implant intraoculaire souple
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
HK1155381A1 (en) Depot formulations of iloperidone with a polymer
EP1604817A3 (de) Klebverschlussband mit vereinzelten elastischen polymerischen Bereichen
EP0627899A4 (de) Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung.
ID24895A (id) Komposisi interpolimer yang dioptimumkan secara komposional, mwd sempit, proses pembuatannya dan artikel yang dibuat, dari padanya
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
IL132120A0 (en) Biodegradable terephthalate polyester-poly (phosphate) polymers compositions articles and methods for making and using the same
HU9501942D0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
CA2343529A1 (en) Antimicrobial acrylic material
DE69832050D1 (de) Implantatmaterial mit glaspartikeln
PT1094771E (pt) Ortese compressiva do tipo meias collants de contencao
WO2001094697A3 (en) Biodegradable coated substrates
DE60029824D1 (de) Zahnprothese mit wirkstoffabgabevorrichtung
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
ATE293438T1 (de) Dämpfwachsperlen zur herstellung von festen formgegenständen
DE59909717D1 (de) Verfahren zur Herstellung von festen Dosierungsformen
DE60018564D1 (de) Funktionsfähige poly-alpha-aminosäurederivate zur modifizierung von biologisch wirksamen stoffen und deren herstellung

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee